Endotoxin and sterility are often mentioned together, which can encourage buyers to treat one result as proof of the other. They are different testing questions. A research-material file should record each requested scope independently and avoid importing pharmaceutical acceptance limits or human-use conclusions into a catalog-material review.
Ask which question was actually tested
Endotoxin testing addresses a defined endotoxin-related analytical scope, while a sterility test addresses growth detection under its stated test conditions. FDA’s current endotoxin guidance discusses testing scope for regulated products. It is authoritative context, not automatic evidence that a research material is a regulated drug or that the guidance’s acceptance framework applies to this order.
Use independent report fields
For each test, record sample identity, method reference, result format, criterion and issuer. The table is a document-review checklist, not a testing protocol or universal required panel. A COA heading saying microbiology does not establish which analyses were performed. Ask for the actual scope. If a requested test was not performed, record not tested rather than interpreting a missing field as a favorable result.
| Field | Endotoxin record | Sterility record |
|---|---|---|
| Question | Defined endotoxin testing scope | Growth-detection test scope |
| Sample | Named tested material | Independently mapped sample |
| Result | Units, basis and qualifiers | Actual stated conclusion and limitations |
| Criterion | Approved relevant requirement | Approved relevant requirement |
| Boundary | Not a sterility conclusion | Not endotoxin evidence or human-use approval |
Do not let one result close the other question
A reported sterility conclusion should not be treated as a substitute for endotoxin evidence, and an endotoxin result should not be relabeled as sterility. Similarly, a closed vial or preservative statement is not either test report. Request separate clarification if the project requires both. Keep each conclusion bounded by its named sample and method rather than extending it automatically to every container, future batch or changed formulation.
Check units and criteria without inventing limits
An endotoxin result may use a stated unit basis that needs comparison with the approved project requirement. Keep inequalities, reporting limits and dilution context visible. A sterility report may use a different result format and scope. Do not convert between the two or borrow a numerical limit from another product. The responsible laboratory reviewer should define the relevant criterion and decide whether the offered evidence addresses it.
Avoid unsupported suitability conclusions
Neither a favorable analytical summary nor a familiar peptide name establishes suitability for human administration. This article does not recommend such use. For research procurement, retain actual reports, open gaps and the review decision. If the project needs additional evidence, request its feasibility and scope before acceptance. Do not upgrade a research catalog description into sterile pharmaceutical status because a document contains one reassuring microbiological result.
Before closing this review
- The two testing questions remain independent.
- Absent tests are not favorable results.
- No external product limit is borrowed.
- Reports do not establish human-use suitability.
Continue with check the scope of a batch report; find or request the relevant batch record. Save the relevant product or guide link alongside the written response so another reviewer can reconstruct the decision.
Editorial scope: research-material procurement and document review. Not medical guidance, dosing instructions or a claim of suitability for human use. Requirements and availability must be confirmed for the quoted material.